These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

613 related items for PubMed ID: 23819496

  • 21. Efficacy and safety of stereotactic ablative radiotherapy in patients with previous pneumonectomy.
    Giaj Levra N, Filippi AR, Guarneri A, Badellino S, Mantovani C, Ruffini E, Ricardi U.
    Tumori; 2015; 101(2):148-53. PubMed ID: 25768317
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Lung Metastases Treated With Stereotactic Ablative Radiation Therapy in Oligometastatic Colorectal Cancer Patients: Outcomes and Prognostic Factors After Long-Term Follow-Up.
    Agolli L, Bracci S, Nicosia L, Valeriani M, De Sanctis V, Osti MF.
    Clin Colorectal Cancer; 2017 Mar; 16(1):58-64. PubMed ID: 27522627
    [Abstract] [Full Text] [Related]

  • 24. Long-Term Outcomes of Salvage Stereotactic Ablative Radiotherapy for Isolated Lung Recurrence of Non-Small Cell Lung Cancer: A Phase II Clinical Trial.
    Sun B, Brooks ED, Komaki R, Liao Z, Jeter M, McAleer M, Balter PA, Welsh JD, O'Reilly M, Gomez D, Hahn SM, Sepesi B, Rice DC, Heymach JV, Chang JY.
    J Thorac Oncol; 2017 Jun; 12(6):983-992. PubMed ID: 28259750
    [Abstract] [Full Text] [Related]

  • 25. Stereotactic ablative radiotherapy (SABR) for treatment of central and ultra-central lung tumors.
    Chaudhuri AA, Tang C, Binkley MS, Jin M, Wynne JF, von Eyben R, Hara WY, Trakul N, Loo BW, Diehn M.
    Lung Cancer; 2015 Jul; 89(1):50-6. PubMed ID: 25997421
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Stereotactic ablative radiotherapy for adrenal gland metastases: Factors influencing outcomes, patterns of failure, and dosimetric thresholds for toxicity.
    Chance WW, Nguyen QN, Mehran R, Welsh JW, Gomez DR, Balter P, Komaki R, Liao Z, Chang JY.
    Pract Radiat Oncol; 2017 Jul; 7(3):e195-e203. PubMed ID: 27743801
    [Abstract] [Full Text] [Related]

  • 28. Stereotactic ablative body radiation therapy for octogenarians with non-small cell lung cancer.
    Takeda A, Sanuki N, Eriguchi T, Kaneko T, Morita S, Handa H, Aoki Y, Oku Y, Kunieda E.
    Int J Radiat Oncol Biol Phys; 2013 Jun 01; 86(2):257-63. PubMed ID: 23570699
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Treatment Outcomes of Stereotactic Ablative Body Radiotherapy on Extra-cranial Oligometastatic and Oligoprogressive Breast Cancer: Mature Results from a Single Institution Experience.
    Armstrong S, Makris A, Belessiotis-Richards K, Abdul-Latif M, Ostler P, Shah N, Miles D, Tsang YM.
    Clin Oncol (R Coll Radiol); 2024 Jun 01; 36(6):362-369. PubMed ID: 38575431
    [Abstract] [Full Text] [Related]

  • 31. Optimizing SABR delivery for synchronous multiple lung tumors using volumetric-modulated arc therapy.
    Tekatli H, Tetar SU, Nguyen TK, Warner A, Verbakel WF, Palma DA, Dahele M, Gaede S, Haasbeek C, Spoelstra FO, de Haan PF, Slotman BJ, Senan S.
    Acta Oncol; 2017 Apr 01; 56(4):548-554. PubMed ID: 28358667
    [Abstract] [Full Text] [Related]

  • 32. Treatment of multiple primary lung cancers using stereotactic radiotherapy, either with or without surgery.
    Griffioen GH, Lagerwaard FJ, Haasbeek CJ, Smit EF, Slotman BJ, Senan S.
    Radiother Oncol; 2013 Jun 01; 107(3):403-8. PubMed ID: 23746675
    [Abstract] [Full Text] [Related]

  • 33. Stereotactic ablative radiotherapy as single treatment for early stage non-small cell lung cancer: A single institution analysis.
    Zheng X, Sun Y, Ye K, Fan C, Wang X, Yang Y, Jiao R, Ge H.
    Thorac Cancer; 2021 Mar 01; 12(6):899-905. PubMed ID: 33529496
    [Abstract] [Full Text] [Related]

  • 34. CyberKnife radiosurgery for stage I lung cancer: results at 36 months.
    Brown WT, Wu X, Fayad F, Fowler JF, Amendola BE, García S, Han H, de la Zerda A, Bossart E, Huang Z, Schwade JG.
    Clin Lung Cancer; 2007 Sep 01; 8(8):488-92. PubMed ID: 17922973
    [Abstract] [Full Text] [Related]

  • 35. Colorectal Histology Is Associated With an Increased Risk of Local Failure in Lung Metastases Treated With Stereotactic Ablative Radiation Therapy.
    Binkley MS, Trakul N, Jacobs LR, von Eyben R, Le QT, Maxim PG, Loo BW, Shultz DB, Diehn M.
    Int J Radiat Oncol Biol Phys; 2015 Aug 01; 92(5):1044-1052. PubMed ID: 26025776
    [Abstract] [Full Text] [Related]

  • 36. Clinical Outcome of Stereotactic Ablative Body Radiotherapy for Lung Metastatic Lesions in Non-small Cell Lung Cancer Oligometastatic Patients.
    De Rose F, Cozzi L, Navarria P, Ascolese AM, Clerici E, Infante M, Alloisio M, Testori A, Toschi L, Finocchiaro G, Santoro A, Scorsetti M.
    Clin Oncol (R Coll Radiol); 2016 Jan 01; 28(1):13-20. PubMed ID: 26385822
    [Abstract] [Full Text] [Related]

  • 37. Stereotactic body radiation therapy for locally advanced and borderline resectable pancreatic cancer is effective and well tolerated.
    Chuong MD, Springett GM, Freilich JM, Park CK, Weber JM, Mellon EA, Hodul PJ, Malafa MP, Meredith KL, Hoffe SE, Shridhar R.
    Int J Radiat Oncol Biol Phys; 2013 Jul 01; 86(3):516-22. PubMed ID: 23562768
    [Abstract] [Full Text] [Related]

  • 38. Dose-escalation study of single-fraction stereotactic body radiotherapy for liver malignancies.
    Goodman KA, Wiegner EA, Maturen KE, Zhang Z, Mo Q, Yang G, Gibbs IC, Fisher GA, Koong AC.
    Int J Radiat Oncol Biol Phys; 2010 Oct 01; 78(2):486-93. PubMed ID: 20350791
    [Abstract] [Full Text] [Related]

  • 39. Stereotactic ablative radiotherapy (SABR) as primary, adjuvant, consolidation and re-treatment option in pancreatic cancer: scope for dose escalation and lessons for toxicity.
    Goldsmith C, Plowman PN, Green MM, Dale RG, Price PM.
    Radiat Oncol; 2018 Oct 19; 13(1):204. PubMed ID: 30340643
    [Abstract] [Full Text] [Related]

  • 40. Stereotactic ablative radiotherapy for reirradiation of locally recurrent lung tumors.
    Trakul N, Harris JP, Le QT, Hara WY, Maxim PG, Loo BW, Diehn M.
    J Thorac Oncol; 2012 Sep 19; 7(9):1462-5. PubMed ID: 22895143
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 31.